Brent Morrison

RHEP CEO Brent Morrison purchased 20,000 shares totaling $27,650.00; stock down -69.0% from 52-week high at $1.07

Brent Morrison, CEO and President of RHEP, executed 3 separate purchases totaling 20,000 shares for $27,650.00 with a blended average price of $1.38, bringing his post-transaction holdings to 17,000 shares. The company is unprofitable (net income $-1.2M in the latest quarter) and trades at a depressed valuation relative to its 52-week range, currently at $1.07 versus a 52-week high of $3.45. His same-ticker history shows 5 prior transactions at RHEP, with the 3 completed buys showing negative 90-day returns (-11.7%, -13.1%, -2.8%), indicating a pattern of purchases that have not appreciated within the measurement window. His cross-ticker track record across 9 prior buys shows a 0.00% win rate at the 90-day mark with an average 90-day return of -23.7%, suggesting a consistent pattern of entry timing that has not resulted in near-term gains.

CEO Brent Morrison purchases 17,000 shares in 2 transactions at $1.27 and $2.01 on 2026-05-20/21; stock now $1.33, down 61.4% from 52-week high

CEO Brent Morrison completed 2 separate purchases totaling 17,000 shares for $30,470.00 at a blended average price of $1.79. The stock currently trades at $1.33, below the transaction prices, and has declined 61.4% from its 52-week high of $3.45. Critically, Morrison's same-ticker history at RHEP shows 0 of 3 prior buy occasions generated positive 90-day returns, with cumulative underperformance ranging from -1.4% to -13.1% over 90 days. His cross-ticker track record across all holdings reflects a 0.00% win rate on 7 prior buys with a -4.3% average 90-day return. The company is unprofitable (net income of -$1.2M on $21.2M quarterly revenue) and trades at a depressed absolute valuation, but the repeated pattern of Morrison's purchases underperforming over medium-term windows, combined with the stock's sharp decline since these transactions were filed, warrants attention to the quality of execution and market conditions driving the timing.

CEO Morrison Brent bought 6,049 shares at $1.45 across 2 transactions; stock down -57.4% from 52-week high despite +16.0% 30-day bounce.

Morrison Brent, CEO and President, made 2 separate purchases totaling 6,049 shares for $8,771.05 on December 9 and December 11, 2025, at $1.45 per share, bringing his holdings to 209,499 shares. The timing of these buys comes as the stock is significantly depressed at -57.4% from its 52-week high of $3.40, though the stock has recovered +16.0% over the prior 30 days. However, his cross-ticker track record shows 5 prior open-market buys with an average 90-day return of -38.4% and a 0.00% win rate over 90 days, suggesting limited success in his prior discretionary purchasing decisions. At the company level, fundamentals present a mixed picture: the latest quarter shows $15.1M revenue with $3.4M net income and +6.8% annual revenue growth, but the company was unprofitable over its most recent full fiscal year, and the P/E ratio of 48.33 appears elevated given recent profitability challenges. This purchase warrants observation given the wide spread between his historical buying outcomes and current valuation context.

CEO Brent Morrison bought 5,403 RHEP shares at $1.41 on 2025-12-04; stock now $1.31, down -61.5% from 52-week high.

Morrison Brent, CEO and President, purchased 5,403 shares at $1.41, increasing holdings to 203,450 shares (+2.7%). The stock has since declined to $1.31, trading 61.5% below its 52-week high of $3.40, though it has recovered 4.8% over the past 30 days after a 29.6% decline over 90 days. Morrison's broader cross-ticker track record shows 5 prior open-market buys with an average 90-day return of -38.4% and a 0.00% win rate, indicating a consistent pattern of purchasing before further declines. At RHEP specifically, this is his second recent transaction (following a buy on 2025-12-09 whose outcomes remain unmeasurable). The company fundamentals present mixed signals: revenue grew 6.8% year-over-year to $15.1M in the latest quarter with $3.4M net income, but full-year results were unprofitable, and the P/E of 43.67 is elevated relative to current profitability. The combination of the CEO's historically poor buy-timing pattern and the stock's severe valuation decline warrant investor scrutiny of the underlying business trajectory.